• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DpdtbA 通过铁蛋白自噬介导的 p53 和 PHD2/hif-1α 通路激活抑制胃癌细胞系中的 EMT。

The DpdtbA induced EMT inhibition in gastric cancer cell lines was through ferritinophagy-mediated activation of p53 and PHD2/hif-1α pathway.

机构信息

College of Basic Medical Science, Xinxiang Medical University, Xinxiang, Henan, PR China.

College of Basic Medical Science, Sanquan College of Xinxiang Medical University, Xinxiang, Henan, PR China.

出版信息

J Inorg Biochem. 2021 May;218:111413. doi: 10.1016/j.jinorgbio.2021.111413. Epub 2021 Mar 4.

DOI:10.1016/j.jinorgbio.2021.111413
PMID:33713969
Abstract

Previous studies have shown that epithelial-mesenchymal transition (EMT) involves reactive oxygen species (ROS) production, but how ferritinophagy-mediated ROS production affects EMT status remains obscure. 2,2'-di-pyridylketone hydrazone dithiocarbamate s-butyric acid (DpdtbA), an iron chelator, exhibited interesting antitumor activities against gastric and esophageal cancer cells. As an extension of our previous research, in this paper we presented the effect of DpdtbA on EMT regulation of gastric cancer lines (SGC-7901 and MGC-803) in both normoxic and hypoxic conditions. The data from immunofluorescent and Western blotting analysis revealed that DpdtbA treatment resulted in EMT inhibition along with downregulation of hypoxia-inducible factor (hif-1α), hinting that prolyl hydroxylase 2 (PHD2) was involved. Knockdown of PHD2 significantly attenuated the action of DpdtbA on EMT regulation, supporting that PHD2 involved the EMT modulation. In addition, the inhibition of EMT involved ROS production that stemmed from DpdtbA induced ferritinophagy; while the accumulation of ferrous iron due to ferritinophagy contributed to PHD2 activation and hif-1α degradation. The correlation analysis revealed that ferritinophagic flux was a dominant driving force in determination of the EMT status. Futhermore, the ferritinophagy-mediated ROS production triggered p53 activation. Taken together, All data supported that DpdtbA induced EMT inhibition was through activation of p53 and PHD2/hif-1α pathway.

摘要

先前的研究表明上皮-间充质转化(EMT)涉及活性氧(ROS)的产生,但铁蛋白自噬介导的 ROS 产生如何影响 EMT 状态尚不清楚。2,2'-二吡啶酮腙二硫代氨基甲酸盐 s-丁基(DpdtbA),一种铁螯合剂,对胃癌和食管癌细胞表现出有趣的抗肿瘤活性。作为我们先前研究的延伸,在本文中,我们介绍了 DpdtbA 在常氧和缺氧条件下对胃癌细胞系(SGC-7901 和 MGC-803)的 EMT 调节作用。免疫荧光和 Western blot 分析的数据表明,DpdtbA 处理导致 EMT 抑制,同时缺氧诱导因子(hif-1α)下调,提示脯氨酰羟化酶 2(PHD2)参与其中。PHD2 的敲低显著减弱了 DpdtbA 对 EMT 调节的作用,支持 PHD2 参与 EMT 调节。此外,EMT 的抑制涉及 ROS 的产生,这源于 DpdtbA 诱导的铁蛋白自噬;而铁蛋白自噬导致的亚铁积累有助于 PHD2 激活和 hif-1α降解。相关性分析表明,铁蛋白自噬通量是决定 EMT 状态的主要驱动力。此外,铁蛋白自噬介导的 ROS 产生触发了 p53 的激活。综上所述,所有数据均支持 DpdtbA 诱导的 EMT 抑制是通过激活 p53 和 PHD2/hif-1α 通路实现的。

相似文献

1
The DpdtbA induced EMT inhibition in gastric cancer cell lines was through ferritinophagy-mediated activation of p53 and PHD2/hif-1α pathway.DpdtbA 通过铁蛋白自噬介导的 p53 和 PHD2/hif-1α 通路激活抑制胃癌细胞系中的 EMT。
J Inorg Biochem. 2021 May;218:111413. doi: 10.1016/j.jinorgbio.2021.111413. Epub 2021 Mar 4.
2
The vicious cycle between ferritinophagy and ROS production triggered EMT inhibition of gastric cancer cells was through p53/AKT/mTor pathway.铁蛋白吞噬作用和 ROS 产生之间的恶性循环抑制了胃癌细胞的 EMT,这是通过 p53/AKT/mTOR 通路实现的。
Chem Biol Interact. 2020 Sep 1;328:109196. doi: 10.1016/j.cbi.2020.109196. Epub 2020 Jul 18.
3
Ferritinophagy-Mediated Ferroptosis and Activation of Keap1/Nrf2/HO-1 Pathway Were Conducive to EMT Inhibition of Gastric Cancer Cells in Action of 2,2'-Di-pyridineketone Hydrazone Dithiocarbamate Butyric Acid Ester.2,2'-二吡啶酮腙二硫代羧酸丁酯通过铁蛋白自噬介导的铁死亡及激活 Keap1/Nrf2/HO-1 通路促进胃癌细胞 EMT 抑制
Oxid Med Cell Longev. 2022 Feb 21;2022:3920664. doi: 10.1155/2022/3920664. eCollection 2022.
4
DpdtC-Induced EMT Inhibition in MGC-803 Cells Was Partly through Ferritinophagy-Mediated ROS/p53 Pathway.DpdtC 通过铁蛋白自噬介导的 ROS/p53 通路抑制 MGC-803 细胞 EMT 发生。
Oxid Med Cell Longev. 2020 Mar 12;2020:9762390. doi: 10.1155/2020/9762390. eCollection 2020.
5
Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells.缺氧诱导因子脯氨酰羟化酶-2介导转化生长因子β1诱导的肾小管上皮细胞间质转化。
Biochim Biophys Acta. 2013 Jun;1833(6):1454-62. doi: 10.1016/j.bbamcr.2013.02.029. Epub 2013 Mar 1.
6
Di-2-pyridylhydrazone Dithiocarbamate Butyric Acid Ester Exerted Its Proliferative Inhibition against Gastric Cell via ROS-Mediated Apoptosis and Autophagy.二吡啶基二硫代氨基甲酸丁酯酸酯通过 ROS 介导的凋亡和自噬对胃细胞发挥增殖抑制作用。
Oxid Med Cell Longev. 2018 Mar 25;2018:4950705. doi: 10.1155/2018/4950705. eCollection 2018.
7
HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway.缺氧诱导因子-1α通过Snail信号通路诱导胃癌干细胞发生上皮-间质转化。
Oncotarget. 2017 Feb 7;8(6):9535-9545. doi: 10.18632/oncotarget.14484.
8
Ferritinophagic Flux Activation in CT26 Cells Contributed to EMT Inhibition Induced by a Novel Iron Chelator, DpdtpA.新型铁螯合剂 DpdtpA 通过激活 CT26 细胞的铁蛋白噬体流抑制 EMT
Oxid Med Cell Longev. 2019 Jun 20;2019:8753413. doi: 10.1155/2019/8753413. eCollection 2019.
9
Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.硒通过脯氨酰羟化酶 2 依赖性和 von Hippel-Lindau 非依赖性降解,抑制肾透明细胞癌细胞中低氧诱导因子 1 和 2α,从而抑制肿瘤生长。
BMC Cancer. 2012 Jul 17;12:293. doi: 10.1186/1471-2407-12-293.
10
miR-21 contributes to renal protection by targeting prolyl hydroxylase domain protein 2 in delayed ischaemic preconditioning.在延迟性缺血预处理中,微小RNA-21通过靶向脯氨酰羟化酶结构域蛋白2发挥肾脏保护作用。
Nephrology (Carlton). 2017 May;22(5):366-373. doi: 10.1111/nep.12787.

引用本文的文献

1
Targeting ferroptosis for neuroprotection: potential therapeutic avenues in neurodegenerative and neuropsychiatric diseases.靶向铁死亡进行神经保护:神经退行性疾病和神经精神疾病的潜在治疗途径
Front Physiol. 2025 Aug 28;16:1641323. doi: 10.3389/fphys.2025.1641323. eCollection 2025.
2
A microfluidic tumor-on-chip platform deciphers hypoxia-driven FOXO3a/PD-L1 signaling in gastric cancer immunotherapy resistance.一种微流控芯片肿瘤平台解析了胃癌免疫治疗耐药中缺氧驱动的FOXO3a/PD-L1信号传导。
Mater Today Bio. 2025 Jun 2;33:101925. doi: 10.1016/j.mtbio.2025.101925. eCollection 2025 Aug.
3
Advances in research regarding epithelial-mesenchymal transition and prostate cancer.
上皮-间质转化与前列腺癌的研究进展
Front Cell Dev Biol. 2025 May 30;13:1583255. doi: 10.3389/fcell.2025.1583255. eCollection 2025.
4
Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects.铁稳态和铁死亡在人类疾病中的作用:机制和治疗前景。
Signal Transduct Target Ther. 2024 Oct 14;9(1):271. doi: 10.1038/s41392-024-01969-z.
5
Prolyl hydroxylase domain enzyme PHD2 inhibits proliferation and metabolism in non-small cell lung cancer cells in HIF-dependent and HIF-independent manners.脯氨酰羟化酶结构域酶PHD2以依赖缺氧诱导因子(HIF)和不依赖HIF的方式抑制非小细胞肺癌细胞的增殖和代谢。
Front Oncol. 2024 Jun 27;14:1370393. doi: 10.3389/fonc.2024.1370393. eCollection 2024.
6
The oral microbiome and oral and upper gastrointestinal diseases.口腔微生物群与口腔及上消化道疾病
J Oral Microbiol. 2024 Jun 3;16(1):2355823. doi: 10.1080/20002297.2024.2355823. eCollection 2024.
7
Targeted ferritinophagy in gastrointestinal cancer: from molecular mechanisms to implications.靶向胃肠道癌铁蛋白自噬:从分子机制到意义。
Arch Toxicol. 2024 Jul;98(7):2007-2018. doi: 10.1007/s00204-024-03745-y. Epub 2024 Apr 11.
8
Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation.铁死亡:癌症与炎症中新兴的机制、生物学功能及治疗潜力
Cell Death Discov. 2024 Jan 24;10(1):45. doi: 10.1038/s41420-024-01825-7.
9
Ferritinophagy: research advance and clinical significance in cancers.铁蛋白自噬:癌症研究进展及临床意义
Cell Death Discov. 2023 Dec 18;9(1):463. doi: 10.1038/s41420-023-01753-y.
10
[Mechanism of miR-186-5p Regulating PRKAA2 to Promote Ferroptosis 
in Lung Adenocarcinoma Cells].[miR-186-5p调控PRKAA2促进肺腺癌细胞铁死亡的机制]
Zhongguo Fei Ai Za Zhi. 2023 Nov 20;26(11):813-821. doi: 10.3779/j.issn.1009-3419.2023.102.39.